Browse by Day Archive

Evommune scraps eczema drug after trial miss, shares plunge

09/08/2026 4:18pm
Evommune said on Tuesday it will not advance ​its experimental skin disease drug after it failed to meet the main goal in ‌a mid-stage trial, sending its shares down 24% in aftermarket ⁠trading.

Is summer heat hurting your trees? The fix may be less water, not more

09/08/2026 12:02pm
Utah's intense summer heat can leave trees looking scorched, tired, or unhealthy, but the solution is not always more water. Learn how proper deep, infrequent watering, soil care, and mulch can help trees better handle late-summer stress.

Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers

09/08/2026 11:02am
Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis' ​treatment for a muscle-wasting disorder failed in a trial, fueling investor concerns about the prospects of similar therapies for the tough-to-treat rare ‌disease.

Amgen-AstraZeneca lung cancer drug combo boosts survival in late-stage trial

09/08/2026 7:15am
Amgen's targeted immunotherapy, Imdelltra, combined with AstraZeneca's cancer drug Imfinzi, significantly ​improved overall survival in patients with extensive-stage small-cell lung cancer in a late-stage trial, the companies said on ‌Tuesday.

Grasshopper populations low in Utah, but homeowners should stay prepared

09/08/2026 7:00am
Grasshopper populations were expected to be high in Utah after a mild winter, but numbers have been surprisingly low across much of the state. Learn why grasshopper outbreaks are difficult to predict and what homeowners can do now to prepare for future infestations.

AI healthcare platform Forus valued at $3 billion in latest funding round

09/08/2026 6:57am
AI healthcare platform Forus said on Tuesday it ​has raised $150 million in a funding round that valued the company at $3 billion, ‌tripling its valuation in about four months.

Utahns flock to Millcreek Canyon for affordable Labor Day getaway

09/08/2026 6:39am
Cooler temperatures on Monday drew hikers, bikers and families to Millcreek Canyon for one last summer outing before fall approaches.

Inhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study

09/08/2026 6:19am
Inhibrx Biosciences said on Tuesday its experimental combination cancer drug helped ​reduce tumors in a mid-stage study in patients with a type of head and neck cancer.

Pharvaris' genetic disorder drug meets main goal in late-stage trial

09/08/2026 5:52am
Pharvaris said on Tuesday its experimental oral drug helped prevent swelling attacks ​in patients with hereditary angioedema, meeting the main goal of a late-stage trial.

Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial

09/08/2026 5:14am
Bristol Myers Squibb said on Tuesday its experimental cell therapy ​showed a high overall response rate in a mid-stage trial, in patients with a hard-to-treat form of blood ‌cancer.

Roivant's experimental lung disease drug meets goals in mid-stage study

09/08/2026 5:00am
Roivant said on Tuesday its experimental drug met the main goals ​of a mid-stage study in patients with high blood pressure associated with a type of lung disease, sending shares up ‌about 17%.

Novartis twin drug trial setbacks pile pressure on pipeline, CEO

09/08/2026 12:05am
Novartis said on Tuesday its experimental drug for a muscle-wasting disorder failed a late-stage study, the second major trial ​setback in days, sending the Swiss drugmaker's shares down about 11% in its worst trading day on record.